MedPath

What is the best treatment and the most cost effective treatment for patients with idiopathic pulmonary fibrosis (IPF): advice on breathlessness, or advice on breathlessness and oxygen to use whilst walking and doing other daily activities at home?

Not Applicable
Completed
Conditions
Idiopathic pulmonary fibrosis (IPF)
Respiratory
Idiopathic Pulmonary Fibrosis
Registration Number
ISRCTN16366011
Lead Sponsor
niversity of Birmingham
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
7
Inclusion Criteria

1. Aged 18 or over
2. Clinically diagnosed IPF, confirmed by an ILD MDT linked to an NHS specialist commissioned IPF service
3. Breathlessness with MRC dyspnoea score =2
4. Willing and able to comply with completion of questionnaires out to 6 months post-randomisation
5. Able to complete a 6MWT or 1 minute sit to stand test
6. Able to use oxygen safely in the opinion of the local investigator

Exclusion Criteria

1. Unable to provide informed consent
2. Requires LTOT, defined by need for resting oxygen in the opinion of the local investigator
3. Life expectancy <6 months
4. On the active transplant list
5. Previous acidotic hypercapnic respiratory failure (AHRF) requiring non-invasive ventilation (NIV)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath